Skip to main content

Insomnia News (Page 7)

Related terms: Difficulty Sleeping, Dyssomnia, Inability to sleep, Sleeplessness, Wakefulness

FDA Medwatch Alert: Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Including Ambien, Ambien CR, Edluar, and Zolpimist    [Posted 01/10/2013] ISSUE: FDA is notifying the public of new information about zolpidem, a widely prescribed insomnia drug. FDA recommends that ...

FDA Approves Intermezzo for Middle-of-the-Night Waking Followed by Difficulty Returning to Sleep

November 23, 2011 – The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night...

Somaxon Announces FDA Approval of Silenor (doxepin) for the Treatment of Insomnia

SAN DIEGO, CA – March 18, 2010 - Somaxon Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Silenor (doxepin) for t...

FDA Medwatch Alert: Sedative-hypnotic drug products

[Posted 03/14/2007] FDA notified healthcare professionals of its request that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Nightmares, Night Terrors, Sleep Disorders

Related drug support groups

gabapentin, trazodone, clonazepam, mirtazapine, amitriptyline, Ativan, lorazepam, Ambien, melatonin, view more... quetiapine, zolpidem, diphenhydramine, temazepam, olanzapine, Tylenol PM, Lunesta, doxepin, valerian, Unisom, Sleep Aid, 5-HTP, phenobarbital